The development of a national strategy on vector-borne diseases including tick-borne diseases was mandated by Congress. To inform development of the national strategy to address vector-borne diseases, HHS is issuing this Request for Information (RFI).
Search Results for: treatment
C. Tagliabue, M. Ed.
Director of Student Personnel and Community Services, (Retired) Jackson Township, New Jersey
More often than not children who contract Lyme Disease are treated with antibiotics for a few months and do not require any additional educational supports or services to make up for lost time in school. This is the rule for the majority of children who contract Lyme Disease, however there are many children who have a difficult time responding to standard treatments, for any number of reasons, and other children who become re-infected one or more times. These children are considered to have “Chronic Lyme Disease.”
Findings from this sample of patients showed that this group of patients reported more severe symptoms than the general population as well as reporting higher than other clinical sample groups including cancer patients and chronic pain patients, and for symptoms of fatigue, women reported higher than men.
In this recent study by Burtis et al. published in the Journal of Medical Entomology, researchers assessed susceptibility of Ixodes scapularis ticks to Permethrin treatment on Shelter Island, NY where […]
In the early decades of Lyme disease up until the early 2000s, it was difficult for researchers who wanted to publish in peer review to be successful due to the controversy surrounding the disease and a climate to suppress important information on Lyme disease. The Journal of Spirochetal & Tick-borne Diseases, of the then LDF, published many articles germane to diagnosis, treatment, symptoms. The International Lyme & Associated Diseases Society (ILADS) is now able to feature those articles, which include early articles on neurologic Lyme and gastrointestinal manifestations, a subject difficult to find even now.
Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement, was published by the American College of Veterinary Internal Medicine (ACVIM). This Consensus statement provides the veterinary community with up-to-date information on the pathophysiology, diagnosis, and treatment of this clinically important animal disease. To date, equine veterinarians have relied heavily on published information on both human and canine Lyme disease in order to have a minimal understanding of Lyme disease in horses. The authors state that additional studies are needed to determine the morbidity in horses infected with B. burgdorferi and to identify the clinical signs specifically associated with Lyme disease in equines.
Congress recently increased annual funding for research on Lyme and related tickborne diseases at NIH by $29 million to a total of $63 million. Most of this is discretionary, although $10 million of it is mandatory for research specific to Lyme disease. In addition to this historic increase, there are opportunities for funding and research support for studies on maternal-fetal transmission of Lyme disease and the impact of pregnancy on immune response. To stimulate researcher interest, NIH has issued a series of notices to encourage investigators to apply for grants and has asked stakeholder organizations for help getting the word out.
The use of botanical medicines in the fight against Babesia duncani is explored in Frontiers in Cellular and Infection Microbiology by Johns Hopins’ Yumin Zhang and a research team.